Interferon Shows Promise Against Chronic Hepatitis Carriers
A Stanford University team reports successful short term use of interferon, a human protein from white blood cells, to clear hepatitis B virus in four long-time carriers. The method, not yet proven for all patients, could aid antiviral drug development and other virus-based illnesses.
MENTIONED IN THIS ARTICLE
Boston
United States
Stanford University
New England Journal of Medicine
Stanford
Williams. Robinson
Robinson
Richard M. Krause
National Institutes of Anergy and Infectious Diseases
Also Mentioned on This Page
Empire Jewelry & Loan CO
Fairfield Ave
Main & Broad Streets
New Court House
University of Bridgeport
Harvey Hubbell Gymnasium
CHUCK
the Legarket
Strafford ‘Ave
TBS
London Broil
Miller'’S Famous
Armour Star
Ars
Kraft Hoe
Hamburg
Kottlei
Dailey's
Georgia
Kottie
E Birdseye
Ilaqtii Fries
Eggo Waffles
Pillsbury
Buttermilk Biscuits